Chronic Pain study: LY4065967
Official title A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
ClinicalTrials.gov ID: NCT07641504
What this study is testing
What is LY4065967?
This is an investigational medicine being studied to see if it can help treat chronic low back pain.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to determine whether the drug is safe and works for treating chronic low back pain.
- Who it's for
- Adults who have chronic low back pain.
- What's involved
- Participants will receive the study drug and attend scheduled visits for medical checks and tests.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have a history of low back pain for at least 3 months located between the 12th thoracic vertebra and the lower gluteal folds, with or without...
- Have a body mass index at screening of ≤40 kilograms per meter squared (kg/m²).
- Have stable glycemic control as indicated by a glycated hemoglobin (HbA1c) less than or equal to 10 at time of screening
You likely can't join if
- Are pregnant or breastfeeding
- Have used a therapeutic injection to the spine in the 3 months prior to screening
- Are using a spinal cord stimulator or dorsal root ganglion stimulator
- Have ongoing complex regional pain syndrome or other concurrent medical conditions that could interfere with the evaluation of CLBP
- Have a history of major spinal deformity, such as spondylolisthesis, spondylolysis, scoliosis, or spina bifida, that causes instability to the spine
- Have an abnormal blood pressure (BP) systolic BP is greater than 140 millimeters mercury (\>140 mm Hg) and diastolic BP\>90 mm Hg at screening Have...
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Palm Springs, California, United States
- Riverside, California, United States
- San Diego, California, United States
- Hamden, Connecticut, United States
- Bradenton, Florida, United States
- DeLand, Florida, United States
- Lady Lake, Florida, United States
- Maitland, Florida, United States
- Merritt Island, Florida, United States
- Miami, Florida, United States
- New Port Richey, Florida, United States
- Ocala, Florida, United States
- Sunrise, Florida, United States
- The Villages, Florida, United States
- Winter Park, Florida, United States
- Woodstock, Georgia, United States
- Chicago, Illinois, United States
- New Orleans, Louisiana, United States
+ 12 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Phoenix, Arizona, United States; Palm Springs, California, United States; Riverside, California, United States; San Diego, California, United States; Hamden, Connecticut, United States and 26 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.